# Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease

> **NCT03467438** · PHASE4 · UNKNOWN · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 80 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Zinc-l-carnosine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03467438
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-22
- **Primary completion:** 2020-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467438, "Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03467438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*